title: Diagnosis and vasculopathy in chronic thromboembolic pulmonary hypertension.
abstract: Chronic thromboembolic pulmonary hypertension (CTEPH) is characterized by pulmonary hypertension caused by nonresolving thromboemboli of the pulmonary artery. However, up to 40% of CTEPH patients have had no clinically apparent acute pulmonary embolic episodes. In addition, both a female predominance and an association of HLA with CTEPH unrelated to deep vein thrombosis are observed in Japan, thus suggesting this condition to be a type of pulmonary vasculopathy. The key for making an accurate diagnosis is to consider CTEPH in any patients with dyspnea on exertion. Perfusion scans provide an excellent noninvasive tool for distinguishing between pulmonary arterial hypertension (PAH) and CTEPH, while CT angiography is useful for differentiating arteritis, tumor, and a congenital anomaly of the pulmonary artery from CTEPH. Pulmonary angiography (PAG) is still considered the gold standard for evaluating CTEPH. No subpleural perfusion in any segments by PAG with high pulmonary vascular resistance is might be related to small vessel disease, thus resulting in a poor outcome after surgery. Recent data suggest a potential therapeutic benefit of antiproliferative therapy for cells isolated from endarterectomized tissue.
authors.affiliation: Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan.
authors.forename: Nobuhiro
authors.initials: N
authors.lastname: Tanabe
keywords: HLA; chronic thromboembolic pulmonary hypertension; perfusion scan; pulmonary angiography; pulmonary vascular remodeling
references.citation: N Engl J Med. 2004 May 27;350(22):2257-64
references.pmid: 15163775
references.citation: Proc Am Thorac Soc. 2006 Sep;3(7):571-6
references.pmid: 16963536
references.citation: N Engl J Med. 2001 Nov 15;345(20):1465-72
references.pmid: 11794196
references.citation: Circ J. 2002 Mar;66(3):257-60
references.pmid: 11922274
references.citation: Am J Respir Crit Care Med. 2001 Jul 15;164(2):319-24
references.pmid: 11463608
references.citation: J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S85-S96
references.pmid: 19555862
references.citation: Circulation. 2002 Mar 5;105(9):1034-6
references.pmid: 11877350
references.citation: Ann Thorac Cardiovasc Surg. 2007 Aug;13(4):267-71
references.pmid: 17717505
references.citation: AJR Am J Roentgenol. 2000 Feb;174(2):509-15
references.pmid: 10658732
references.citation: Circulation. 2007 Apr 24;115(16):2153-8
references.pmid: 17420352
references.citation: N Engl J Med. 2003 Feb 6;348(6):500-9
references.pmid: 12571257
references.citation: Eur Respir J. 2005 Jan;25(1):131-8
references.pmid: 15640334
references.citation: N Engl J Med. 2004 Jun 17;350(25):2558-63
references.pmid: 15201412
references.citation: J Hum Genet. 2009 Feb;54(2):108-14
references.pmid: 19165231
references.citation: Circ J. 2008 Dec;72(12):2069-74
references.pmid: 18931448
references.citation: Nihon Kokyuki Gakkai Zasshi. 2005 Dec;43(12):755-60
references.pmid: 16457339
references.citation: Eur Respir J. 2001 Apr;17(4):653-9
references.pmid: 11401060
references.citation: Circulation. 2009 Jan 20;119(2):298-305
references.pmid: 19118254
references.citation: Circulation. 2006 Apr 25;113(16):2011-20
references.pmid: 16636189
references.citation: Am J Respir Crit Care Med. 1999 Aug;160(2):523-8
references.pmid: 10430723
references.citation: Circulation. 2004 Jan 6;109(1):18-22
references.pmid: 14699009
references.citation: Circ J. 2008 Jul;72(7):1136-41
references.pmid: 18577824
references.citation: Radiology. 1992 Feb;182(2):393-8
references.pmid: 1732955
references.citation: Am J Physiol Lung Cell Mol Physiol. 2009 Oct;297(4):L666-76
references.pmid: 19633069
references.citation: Hum Immunol. 2006 Apr-May;67(4-5):363-73
references.pmid: 16720219
references.citation: Circ J. 2008 Jun;72(6):958-65
references.pmid: 18503223